Xilio Therapeutics, Inc.
XLO
$8.46
-$0.05-0.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 137.53M | 103.76M | 121.55M | 89.07M | 55.29M |
| Total Receivables | 5.00M | 17.50M | -- | 2.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.50M | 2.83M | 2.17M | 2.13M | 4.94M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 145.03M | 124.09M | 123.72M | 93.20M | 60.23M |
|
|
|||||
| Total Current Assets | 145.03M | 124.09M | 123.72M | 93.20M | 60.23M |
| Net Property, Plant & Equipment | 7.85M | 7.80M | 8.30M | 8.73M | 9.06M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.81M | 1.80M | 1.79M | 1.79M | 1.78M |
| Total Assets | 154.69M | 133.69M | 133.81M | 103.72M | 71.08M |
|
|
|||||
| Total Accounts Payable | 3.17M | 2.30M | 4.10M | 2.28M | 2.57M |
| Total Accrued Expenses | 11.74M | 8.95M | 5.62M | 3.88M | 9.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.34M | 1.30M | 1.26M | 1.23M | 1.19M |
| Total Finance Division Other Current Liabilities | 40.02M | 43.85M | 42.28M | 40.25M | 13.52M |
| Total Other Current Liabilities | 40.02M | 43.85M | 42.28M | 40.25M | 13.52M |
| Total Current Liabilities | 56.27M | 56.40M | 53.26M | 47.64M | 27.26M |
|
|
|||||
| Total Current Liabilities | 56.27M | 56.40M | 53.26M | 47.64M | 27.26M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.61M | 5.96M | 6.30M | 6.64M | 6.95M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 57.53M | 79.43M | 67.18M | 38.74M | 19.26M |
| Total Liabilities | 119.41M | 141.79M | 126.74M | 93.02M | 53.48M |
|
|
|||||
| Common Stock & APIC | 454.06M | 421.05M | 419.93M | 407.72M | 401.35M |
| Retained Earnings | -418.79M | -429.15M | -412.86M | -397.02M | -383.75M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 35.27M | -8.10M | 7.07M | 10.70M | 17.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 35.27M | -8.10M | 7.07M | 10.70M | 17.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 35.27M | -8.10M | 7.07M | 10.70M | 17.60M |
|
|
|||||